Delivery Order SPE2DB22D3301-SPE2DB24FY2RM

Award Date 3/15/24
Potential Completion Date 3/18/24
Potential Value $6.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of DESCOVY 200-25 MG TABLET, a prescription medication, with a ceiling value of $11,157.47 and a performance period through April 12, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a ceiling value of $11,113.25 and a period of performance through April 15, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,244.30, is for the supply of DESCOVY 200-25 MG TABLET 30S, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of medical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the pharmaceutical product DESCOVY 200-25 MG TABLET and has a ceiling value of $29,999.49. The order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 held by AmerisourceBergen Drug Corp as the sole awardee, which serves as the primary contract...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of DESCOVY 200-25 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. The contract has a ceiling value of $18,690.77 and a period of performance through March 22, 2024. This delivery order is issued under a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $12,626.52 and an ultimate completion date of December 18, 2024. The contract is for the provision of DESCOVY 200-25 MG TABLET, a prescription medication, to support federal healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The $8,240.08 award is for the supply of DESCOVY 200-25 MG TABLET 30S, a pharmaceutical product, with a period of performance through April 4, 2024. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical and medical products and services to U.S....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product, with a potential value of $11,193.36 and a performance period through March 7, 2024. This award is part of a larger indefinite delivery contract...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $82,726.96, is for the delivery of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. This delivery order was issued under an Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with DLA, with a potential value of up to $999,999,999.00 and a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET UU 30S at a ceiling value of $2,831.08. The order is a firm fixed-price contract with a completion date of January 3, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY2RM
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of DESCOVY 200-25 MG TABLET, a specialty pharmaceutical product, with a ceiling value of $6,529.80 and a period of performance through March 18, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide in support of the Department of Defense. No set-aside designation was used for this award.

Generated 6/14/24, 9:53 AM